Production of Retroviral Vectors: Review

被引：0

作者：

Coroadinha, Ana S. ^{[1
]}

Gama-Norton, Leonor ^{[1
,2
]}

Amaral, Ana I. ^{[1
]}

Hauser, Hansjorg ^{[2
]}

Alves, Paula M. ^{[1
]}

Cruz, Pedro E. ^{[1
,3
]}

机构：

[1] ITQB UNL IBET, P-2780901 Oeiras, Portugal

[2] Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany

[3] ECBio, P-2781901 Oeiras, Portugal

来源：

CURRENT GENE THERAPY | 2010年 / 10卷 / 06期

关键词：

Packaging cells; production; purification; retrovirus; PACKAGING CELL-LINE; MURINE LEUKEMIA-VIRUS; SEVERE COMBINED IMMUNODEFICIENCY; REPLICATION-COMPETENT RETROVIRUS; CHRONIC GRANULOMATOUS-DISEASE; DEFINED CHROMOSOMAL LOCI; SINGLE-CHAIN ANTIBODIES; VIVO GENE DELIVERY; SERUM-FREE MEDIA; HIGH-TITER;

D O I：

暂无

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

Retroviral vectors are presently amongst the most widely used vectors in gene therapy clinical trials to target pathologies of different origins, such as cancers, genetic diseases or neurological disorders. This review provides an overview on the evolution of retroviral vector design and production for gene therapy applications, including state of the art developments in flexible producer cells and safe vectors. In addition, production and purification processes will be addressed, with a particular focus on the improvements undertaken to increase vector productivity and to reduce the rapid loss of infectivity, which presently represent the main challenges in retroviral vectors production for gene therapy.

引用

页码：456 / 473

页数：18

共 50 条

[1] State-of-the-art of the production of retroviral vectors
Merten, OW
[J]. JOURNAL OF GENE MEDICINE, 2004, 6 : S105 - S124
[2] Integrated Strategy for the Production of Therapeutic Retroviral Vectors
Carrondo, Manuel
Panet, Amos
Wirth, Dagmar
Coroadinha, Ana Sofia
Cruz, Pedro
Falk, Haya
Schucht, Roland
Dupont, Francis
Geny-Fiamma, Cecile
Merten, Otto-Wilhelm
Hauser, Hansjoerg
[J]. HUMAN GENE THERAPY, 2011, 22 (03) : 370 - 379
[3] Adenovirus vectors as transcomplementing templates for the production of replication defective retroviral vectors
Ramsey, WJ
Caplen, NJ
Li, Q
Higginbotham, JN
Shah, M
Blaese, RM
[J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 246 (03) : 912 - 919
[4] Optimization of the production of retroviral vectors -: Influences of the sugar source
Gény-Fiamma, C
Millot, L
Rocca, C
Danos, O
Merten, OW
[J]. ANIMAL CELL TECHNOLOGY: BASIC & APPLIED ASPECTS, VOL 13, 2003, : 89 - 97
[5] Production of transgenic birds using pantropic retroviral vectors
Mizuarai, S
Ono, K
Kanbayashi, K
Nishijima, K
Kamihira, M
Iijima, S
[J]. ANIMAL CELL TECHNOLOGY : BASIC & APPLIED ASPECTS, VOL 12, 2002, : 287 - 291
[6] RETROVIRAL VECTORS
LEVER, AML
[J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 1991, 19 (02) : 379 - 383
[7] Retroviral vectors
Kurian, KM
Watson, CJ
Wyllie, AH
[J]. JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY, 2000, 53 (04): : 173 - 176
[8] RETROVIRAL VECTORS
MILLER, AD
[J]. CURRENT TOPICS IN MICROBIOLOGY AND IMMUNOLOGY, 1992, 158 : 1 - 24
[9] Retroviral vectors
Kim, SH
Kim, SY
Robbins, PD
[J]. ADVANCES IN VIRUS RESEARCH, VOL 55, 2000, 55 : 545 - 563
[10] Retroviral Vectors
M. Schweizer
E. Flory
C. J. Buchholz
K. Cichutek
[J]. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 2001, 44 (11) : 1038 - 1046

← 1 2 3 4 5 →